FBXW7 mutations were mutually exclusive with CTNNB1 (p < 0.0001) and more common in left-sided/MSS cancers, often co-occurring with TP53 and KRAS alterations, consistent with previous findings in stage II CRC [80]. The gene discussed is TP53; the disease is cancer.